Sulfate conjugation is an important pathway in the metabolism of many drugs, other xenobiotic compounds, hormones, and neurotransmitters. During the past two decades, the applicant's laboratory has systematically explored the pharmacogenetics of enzymes that catalyze sulfation in humans. As a result of application of the techniques of molecular biology, at least nine separate sulfotransferase (SULT) enzymes have now been identified in humans, including three phenol SULTs (1A1, 1A2, AND 1A3) that play an important role in the biotransformation of a large number of drugs. The applicant's laboratory demonstrated previously, at the biochemical level, that expression of phenol SULT activities in humans are controlled by genetic polymorphisms. In pursuit of those observations, the laboratory has recently cloned the genes for all three phenol SULTs in humans- a requirement for studies of molecular mechanisms responsible for the pharmacogenetic regulation of phenol sulfation in humans. It is now proposed to comprehensively define molecular genetic mechanisms involved in the regulation of the expression and function of phenol SULTs in humans by identifying polymorphisms within phenol SULT exons, 5'-flanking sequences and introns and determining which of these polymorphisms might be functionally significant. We will also expand our studies of sulfation pharmacogenetics in humans to include PAPS synthetase, the enzyme that catalyzes the synthesis of 3'-phosphoadenosine-5'-phosphosulfate (PAPS), the sulfate donor for all mammalian SULT enzymes. We have already cloned the cDNA for this enzyme. We now propose to clone its gene and to determine possible molecular genetic mechanisms involved in differences among individuals in its expression and/or biochemical properties. The results of these experiments will increase our understanding of molecular mechanisms responsible for the genetic regulation of enzymes that catalyze the sulfate conjugation of drugs, other xenobiotic compounds, hormones and neurotransmitters in humans and may make it possible to predict individual variations in the sulfation and therefore, the effect or toxicity of these compounds.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM035720-17
Application #
6489999
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Long, Rochelle M
Project Start
1986-01-01
Project End
2003-11-30
Budget Start
2002-01-01
Budget End
2003-11-30
Support Year
17
Fiscal Year
2002
Total Cost
$289,520
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Monte, Andrew A; Anderson, Peter; Hoppe, Jason A et al. (2015) Accuracy of Electronic Medical Record Medication Reconciliation in Emergency Department Patients. J Emerg Med 49:78-84
Srinivasan, Balaji S; Chen, Jinbo; Cheng, Cheng et al. (2009) Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group. Pharmacogenomics 10:243-51
Feng, Qiping; Keshtgarpour, Mani; Pelleymounter, Linda L et al. (2009) Human S-adenosylhomocysteine hydrolase: common gene sequence variation and functional genomic characterization. J Neurochem 110:1806-17
Aksoy, Pinar; Zhu, Min Jia; Kalari, Krishna R et al. (2009) Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics. Pharmacogenet Genomics 19:567-76
Furimsky, Anna M; Green, Carol E; Sharp, Lewanne E Hunt et al. (2008) Effect of resveratrol on 17beta-estradiol sulfation by human hepatic and jejunal S9 and recombinant sulfotransferase 1E1. Drug Metab Dispos 36:129-36
Kocabas, Neslihan Aygun; Aksoy, Pinar; Pelleymounter, Linda L et al. (2008) Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics. Drug Metab Dispos 36:1951-9
Ji, Yuan; Olson, Janet; Zhang, Jianping et al. (2008) Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res 68:5997-6005
Li, Fang; Wang, Liewei; Burgess, Rebecca J et al. (2008) Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation. Pharmacogenet Genomics 18:1083-94
Li, Fang; Feng, Qiping; Lee, Candace et al. (2008) Human betaine-homocysteine methyltransferase (BHMT) and BHMT2: common gene sequence variation and functional characterization. Mol Genet Metab 94:326-35
Moyer, Ann M; Salavaggione, Oreste E; Wu, Tse-Yu et al. (2008) Glutathione s-transferase p1: gene sequence variation and functional genomic studies. Cancer Res 68:4791-801

Showing the most recent 10 out of 86 publications